메뉴 건너뛰기




Volumn 16, Issue 9, 1997, Pages 1017-1029

Adjusting for non-compliance and contamination in randomized clinical trials

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; HUMAN; PATIENT COMPLIANCE; RANDOMIZED CONTROLLED TRIAL; STATISTICAL ANALYSIS; STATISTICS;

EID: 0031005036     PISSN: 02776715     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0258(19970515)16:9<1017::AID-SIM508>3.0.CO;2-V     Document Type: Article
Times cited : (260)

References (15)
  • 1
    • 0025290260 scopus 로고
    • Randomized consent designs for clinical trials: An update
    • Zelen, M. 'Randomized consent designs for clinical trials: an update', Statistics in Medicine, 9, 645-656 (1990).
    • (1990) Statistics in Medicine , vol.9 , pp. 645-656
    • Zelen, M.1
  • 3
    • 0025968778 scopus 로고
    • On estimating efficacy from clinical trials
    • Sommer, A. and Zeger, S. L. 'On estimating efficacy from clinical trials', Statistics in Medicine, 10, 45-52 (1991).
    • (1991) Statistics in Medicine , vol.10 , pp. 45-52
    • Sommer, A.1    Zeger, S.L.2
  • 4
    • 0000097066 scopus 로고
    • The efficiency of the proportions test and the logrank test for censored survival data
    • Cuzick, J. 'The efficiency of the proportions test and the logrank test for censored survival data', Biometrics, 38, 1033-1039 (1982).
    • (1982) Biometrics , vol.38 , pp. 1033-1039
    • Cuzick, J.1
  • 7
    • 0027531693 scopus 로고
    • Prevention of colorectal cancer by once-only sigmoidoscopy
    • Atkin, W. S., Cuzick, J., Northover, J. M. A. and Whynes, D. K. 'Prevention of colorectal cancer by once-only sigmoidoscopy', Lancet, 341, 736-740 (1993).
    • (1993) Lancet , vol.341 , pp. 736-740
    • Atkin, W.S.1    Cuzick, J.2    Northover, J.M.A.3    Whynes, D.K.4
  • 8
    • 0001015983 scopus 로고
    • Correcting for non-compliance in randomized trials using rank preserving structural failure time models
    • Robins, J. M. and Tsiatis, A. A. 'Correcting for non-compliance in randomized trials using rank preserving structural failure time models', Communications in Statistics, Part A - Theory and Methods 20, 2609-2631 (1991).
    • (1991) Communications in Statistics, Part A - Theory and Methods , vol.20 , pp. 2609-2631
    • Robins, J.M.1    Tsiatis, A.A.2
  • 9
    • 21844517537 scopus 로고
    • Adjusting for differential rates of prophylaxis therapy for PCP in high-versus low-dose AZT treatment arms in an AIDS randomized trial
    • Robins, J. M. and Greenland, S. 'Adjusting for differential rates of prophylaxis therapy for PCP in high-versus low-dose AZT treatment arms in an AIDS randomized trial', Journal of the American Statistical Society, 89, 737-749 (1994).
    • (1994) Journal of the American Statistical Society , vol.89 , pp. 737-749
    • Robins, J.M.1    Greenland, S.2
  • 10
    • 0018750520 scopus 로고
    • A new design for randomised clinical trials
    • Zelen, M. 'A new design for randomised clinical trials, New England Journal of Medicine, 300, 1242-1245 (1979).
    • (1979) New England Journal of Medicine , vol.300 , pp. 1242-1245
    • Zelen, M.1
  • 13
    • 0000596503 scopus 로고
    • Modified signed log likelihood ratio
    • Barndorff-Nielsen, O. E. 'Modified signed log likelihood ratio', Biometrika, 78, 557-563 (1991).
    • (1991) Biometrika , vol.78 , pp. 557-563
    • Barndorff-Nielsen, O.E.1
  • 14
    • 0023230928 scopus 로고
    • What is the optimum interval between mammographic screening examinations? - An analysis based on the latest results of the Swedish two-county breast cancer screening trial
    • Tabár, L., Fagerberg, G., Day, N. E. and Holmberg, L. 'What is the optimum interval between mammographic screening examinations? - An analysis based on the latest results of the Swedish two-county breast cancer screening trial, British Journal of Cancer, 55, 547-551 (1987).
    • (1987) British Journal of Cancer , vol.55 , pp. 547-551
    • Tabár, L.1    Fagerberg, G.2    Day, N.E.3    Holmberg, L.4


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.